Chronic Fatigue Syndrome Trial, Recruiting NCT05525598 Sponsor: University of Aarhus Condition: Chronic Fatigue Syndrome
Back to Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Trial, Recruiting

NCT05525598
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must have been diagnosed with a moderate-severe form of a condition involving unexplained physical symptoms affecting multiple areas of the body (specifically, at least 2 body systems each with 3 or more symptoms, or 3–4 body systems each with 3 or more symptoms) — (confirm with trial site if unsure about your diagnosis).
  • Your symptoms must have been present for more than 6 months.
  • If you are older than 25, you must have been working or studying for at least 12 months within the last 2 years.
  • You must have access to a computer or tablet with an internet connection.
  • You must be able to understand, read, and write Danish fluently.

Who may not be able to join:

  • You may not be able to join if you have a serious physical or mental health condition that is not well managed and could make it difficult for you to take part in the treatment.
  • You may not be able to join if you are not willing or motivated to take part in an online treatment programme.
  • You may not be able to join if you feel you have poor skills using computers or the internet.
  • You may not be able to join if you are not able or willing to give your informed consent to participate.
  • You may not be able to join if you are currently taking opioid painkillers or benzodiazepine medications (such as certain sleeping tablets or anxiety medications).
  • You may not be able to join if your use of medications that affect mood or mental health has not been at a stable, consistent level recently.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lisbeth Frostholm, Ph.D., Aarhus Universityhospital

Phone: 61147069

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 August 2022
Est. completion
30 April 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Change in SF-36 physical health (SF-36 PPH scales); Clinical Global Improvement Scale (CGI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov